Sinopharm IPO sells out on first day of bookbuilding
Sinopharm Group, the Chinese pharmaceutical distributor, looked to be heading for a big oversubscription on its $1.1bn Hong Kong initial public offering on Friday after the deal was fully covered on the first day of bookbuilding.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts